TuisGEDSF • OTCMKTS
add
Gedeon Richter ADR
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(HUF) | Sep. 2024info | J/J-verandering |
---|---|---|
Inkomste | 216,73 mjd | 14,95% |
Bedryfskoste | 94,69 mjd | 10,59% |
Netto inkomste | 37,06 mjd | -32,07% |
Netto winsgrens | 17,10 | -40,89% |
Wins per aandeel | — | — |
EBITDA | 76,39 mjd | 23,89% |
Effektiewe belastingkoers | 19,13% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(HUF) | Sep. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 74,99 mjd | -29,24% |
Totale bates | 1,49 bn | 9,53% |
Totale aanspreeklikheid | 258,83 mjd | -1,37% |
Totale ekwiteit | 1,23 bn | — |
Uitstaande aandele | 182,62 m | — |
Prys om te bespreek | 0,00 | — |
Opbrengs op bates | 10,29% | — |
Opbrengs op kapitaal | 11,59% | — |
Kontantvloei
Netto kontantverandering
(HUF) | Sep. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | 37,06 mjd | -32,07% |
Kontant van bedrywe | 67,55 mjd | 56,30% |
Kontant van beleggings | -13,69 mjd | 54,12% |
Kontant van finansiering | -36,70 mjd | -409,23% |
Netto kontantverandering | 17,12 mjd | -34,71% |
Beskikbare kontantvloei | 13,19 mjd | 1 594,12% |
Meer oor
Gedeon Richter Plc. is a European multinational pharmaceutical and biotechnology company headquartered in Budapest. It is the largest pharmaceutical company in Central and Eastern Europe, with an expanding direct presence in Western Europe, China, Northern America and Latin America. Richter has the largest R&D unit in Central and Eastern Europe and operations in over 100 countries.
Gedeon Richter Plc. has a primary listing on the Budapest Stock Exchange and is a constituent of the BUX Index. It had a market capitalisation of approximately $6.6 billion as of 2018, the third largest of companies with a primary listing on the Budapest Stock Exchange. It has secondary listings on the Luxembourg Stock Exchange.
Richter sells products for the central nervous system, women's health and cardiovascular therapeutic areas among others. The company is also active in biosimilar product development. The company was established in Budapest by Gedeon Richter, a pharmacist, in 1901. Wikipedia
HUB
Gestig
1901
Webwerf
Werknemers
11 603